| IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly P Stenvinkel, M Ketteler, RJ Johnson, B Lindholm, R Pecoits-Filho, ... Kidney international 67 (4), 1216-1233, 2005 | 1274 | 2005 |
| Aspects of immune dysfunction in end-stage renal disease S Kato, M Chmielewski, H Honda, R Pecoits-Filho, S Matsuo, Y Yuzawa, ... Clinical Journal of the American Society of Nephrology 3 (5), 1526-1533, 2008 | 1270 | 2008 |
| Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ... The Lancet 390 (10105), 1888-1917, 2017 | 994 | 2017 |
| Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD H Honda, AR Qureshi, O Heimbürger, P Barany, K Wang, R Pecoits-Filho, ... American Journal of Kidney Diseases 47 (1), 139-148, 2006 | 710 | 2006 |
| The malnutrition, inflammation, and atherosclerosis (MIA) syndrome–the heart of the matter R Pecoits‐Filho, B Lindholm, P Stenvinkel Nephrology dialysis transplantation 17 (suppl_11), 28-31, 2002 | 620 | 2002 |
| Changes in the worldwide epidemiology of peritoneal dialysis PKT Li, KM Chow, MWM Van de Luijtgaarden, DW Johnson, KJ Jager, ... Nature Reviews Nephrology 13 (2), 90-103, 2017 | 597 | 2017 |
| Associations between circulating inflammatory markers and residual renal function in CRF patients R Pecoits-Filho, O Heimbürger, P Bárány, M Suliman, I Fehrman-Ekholm, ... American journal of kidney diseases 41 (6), 1212-1218, 2003 | 586 | 2003 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 543 | 2019 |
| Interleukin‐6 is an independent predictor of mortality in patients starting dialysis treatment R Pecoits‐Filho, P Bárány, B Lindholm, O Heimbürger, P Stenvinkel Nephrology Dialysis Transplantation 17 (9), 1684-1688, 2002 | 529 | 2002 |
| Left ventricular mass in chronic kidney disease and ESRD RJ Glassock, R Pecoits-Filho, SH Barberato Clinical Journal of the American Society of Nephrology 4 (Supplement_1), S79-S91, 2009 | 481 | 2009 |
| Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin P Stenvinkel, K Wang, AR Qureshi, J Axelsson, R Pecoits-Filho, P Gao, ... Kidney international 67 (6), 2383-2392, 2005 | 457 | 2005 |
| Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CM Clase, JJ Carrero, DH Ellison, ME Grams, BR Hemmelgarn, ... Kidney international 97 (1), 42-61, 2020 | 419 | 2020 |
| Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference AA House, C Wanner, MJ Sarnak, IL Piña, CW McIntyre, P Komenda, ... Kidney international 95 (6), 1304-1317, 2019 | 364 | 2019 |
| Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem P Stenvinkel, R Pecoits-Filho, B Lindholm Journal of the American Society of Nephrology 14 (7), 1927-1939, 2003 | 362 | 2003 |
| Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? P Stenvinkel, P Barany, O Heimbürger, R Pecoits-Filho, B Lindholm Kidney international 61, S103-S108, 2002 | 342 | 2002 |
| Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference MP Turakhia, PJ Blankestijn, JJ Carrero, CM Clase, R Deo, CA Herzog, ... European heart journal 39 (24), 2314-2325, 2018 | 289 | 2018 |
| Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease AK Cheung, TI Chang, WC Cushman, SL Furth, FF Hou, JH Ix, GA Knoll, ... Kidney international 99 (3), 559-569, 2021 | 282 | 2021 |
| A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy DC Wheeler, RD Toto, BV Stefansson, N Jongs, GM Chertow, T Greene, ... Kidney international 100 (1), 215-224, 2021 | 277 | 2021 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 265 | 2016 |
| KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease AK Cheung, TI Chang, WC Cushman, SL Furth, FF Hou, JH Ix, GA Knoll, ... Kidney International 99 (3), S1-S87, 2021 | 262 | 2021 |
Peter StenvinkelProfessor i NjurmedicinEmail verificata su ki.se
